Skip to main content
Premium Trial:

Request an Annual Quote

Mobilion Closes $35M Series B Funding Round

NEW YORK – Separations firm Mobilion Systems said Monday it has closed a $35 million Series B funding round.

The Chadds Ford, Pennsylvania-based company said it plans to use the funds to support the launch of its first product based on its structures for lossless ion manipulation (SLIM) ion mobility system and to expand its product portfolio to take on pharma QC and diagnostic applications.

Developed at Pacific Northwest National Laboratory, the SLIM technology extends ion mobility path lengths beyond those allowed by conventional ion mobility spectrometry systems, potentially enabling much more extensive separations, which could aid in a range of mass spec-based research areas, including characterization of biologic drugs and protein biomarker discovery.

The round was led by aMoon, with the remaining funds contributed by existing investors, including Agilent Technologies, IP Group, Hostplus, and Cultivation Capital.

"We are very excited to have aMoon join our existing community of investors, who collectively share our vision to advance healthcare and improve how we predict, diagnose, and treat disease by revealing molecules that other instruments leave unseen," Mobilion CEO Melissa Sherman said in a statement. "This round of financing will augment our sales and marketing efforts and accelerate the development of second-generation products."

The company closed a $15.4 million Series A round last year.